Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations.

Genetic testing - 1 Jan 2002

Armstrong Katrina, Stopfer Jill, Calzone Kathleen, Fitzgerald Genevieve, Coyne James, Weber Barbara

Abstract excerpt

The traditional emphasis on nondirectiveness in genetic counseling has become increasingly controversial with the rapid expansion of genetic testing in clinical medicine. This study was done to determine whether women considering clinical testing for BRCA1/2 mutations want to know their health care providers' opinions about whether or not they should undergo testing. Participating in the study was a retrospective...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Ovarian Neoplasms

Share to Physician-Patient Relations

Share to Risk Assessment

Share to Truth Disclosure

Source

Identifiers

PMID: 12215250
DOI: 10.1089/10906570260199366

Genes

BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations.PMID 12215250Read ↗

What Research Participants Want to Know About Genetic Research Results: The Impact of “Genetic Exceptionalism”Semantic proximity Read ↗

Factors associated with decisions about clinical BRCA1/2 testing.Semantic proximity Read ↗

Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.Semantic proximity Read ↗

The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.Semantic proximity Read ↗

Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer.Semantic proximity Read ↗

Preferences regarding genetic research results: comparing veterans and nonveterans responses.Semantic proximity Read ↗

Patient preferences of decision-making in the context of genetic testing for breast cancer risk.Semantic proximity Read ↗

What patients and their relatives think about testing for BMPR2.Semantic proximity Read ↗

Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.Semantic proximity Read ↗

Patients' willingness to reconsider cancer genetic testing after initially declining: Mention it againSemantic proximity Read ↗

The effects of 'non-directive' questioning on an anticipated decision whether to undergo predictive testing for heart disease: an experimental study.Semantic proximity Read ↗

The knowledge about risk for breast cancer: the patients' right to know.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.